Skip to main content

Oregon State Flag An official website of the State of Oregon »

Oregon Health Authority logo

Oregon Opioid Settlement Funds

About Oregon Opioid Settlement Funds

The opioid crisis has caused profound and lasting harm in Oregon and across the nation. For decades, pharmaceutical companies contributed to this crisis by aggressively marketing opioid medications, funding biased research, and downplaying the risks while exaggerating the benefits of opioids for chronic pain.

Since 2021, Oregon has joined national settlements with several of these companies. Through these agreements, the state will receive more than $760 million in payments from 2022 through 2039, with additional settlements expected to increase this amount over time.

Settlement funds are divided between the state (45%) and local govenments (55%). The Opioid Settlement Prevention, Treatment and Recovery (OSPTR) Board, an 18-member advisory board established by 2022 House Bill 4098, decides how the state’s share is allocated. The Oregon Health Authority (OHA) administers the OSPTR Fund, supports the Board, and manages Board-funded programs.

The OSPTR Board allocated 30% of the state's share to the Nine Federally Recognized Tribes of Oregon. This funding will continue for the full life of the settlements, totaling an estimated $88.3 million.

OHA publicly tracks all opioid settlement spending. For answers to common questions, visit the Frequently Asked Questions page.

Understanding Oregon's Opioid Settlement Board Spending

The OSPTR Board determines how the state's portion of opioid settlement funds are awarded. Opioid settlement funds do not go directly to individuals.

The Board has allocated over $116.5 million across several areas, including prevention, harm reduction, treatment, recovery, and research.

A data dashboard showing real-time allocations and spending is coming in 2026.

The OSPTR Board

Meetings and Public Participation

The OSPTR Board typically meets on the first Wednesday of every month from 10am-1pm PST.

The Board’s Research, Evaluation, and Data (RED) Subcommittee makes spending recommendations for research, evaluation, and data-related funding. The Subcommittee typically meets on the third Wednesday of each month from 9 a.m.–10:30 a.m.

All meetings are open to the public. Community members are welcome to provide spoken or written testimony during the public comment portion of each meeting. Participants may also sign up for comment during meetings using the chat feature. Written testimony may be subbitted at any time by emailing  OHA.OpioidSettlement@odhsoha.oregon.gov. Meeting reocordings, summaries are posted on the OSPTR Board Meeting Archive page within a few days of each meeting.

Cities and counties receiving settlement funds are invited to participate in the Local Opioid Settlement Learning Collaborative a monthly virtual series where participants share updates and best practices for settlement spending. Meeting recordings, slides, and a quarterly newsletter are available on the ADPC website. For more information or to join the listserv, visit https://www.oregon.gov/adpc/pages/local-opioid-settlement-learning-collaborative.aspx or email opioidsettlementcollaborative@comagine.org.

Board Membership

The OSPTR Board consists of 18 members representing state agencies, local governments, communities, and people with lived experience of substance use disorder.

​​​​​​
​​1. A policy advisor to the Governor​
April Rohman​
Behavioral Health​​ Advisor
Office of Governor Tina Kotek​
​​
​​​​​​​​​​2. A representative of the Department of Justice,
Adria Decker, JD, PhD
Health Fraud Analyst
Economic Justice Section
Civil Enforcement Division
Oregon Department of Justice

​ ​
​​​​3. ​A representative of the Oregon Health Authority
John W. McIlveen, PhD, LMHC
State Opioid Treatment Authority,
Oregon Health Authority

​4. A representative of the Department of Human Services
Tami Kane-Suleiman, MSW
Child Fatality Prevention & Review Program Manager,
Oregon Department of Human Services

​5. The Director of the Alcohol and Drug Policy Commission​
Annaliese Dolph, JD ​​​
Director, Alcohol and Drug Policy Commission,​​​
​6. The Chairperson of the Oversight and Accountability Council ​
​established in ORS 430.388 or designee
​​Zebuli Payne, CADCII​​
Clinical Director,
Phoenix Wellness Center​​


​7. An individual representing Clackamas, Washington, or Multnomah County
Nicholas Ocón, LCSW
Behavioral Health Division Manager,
Washington County Dept. of Health and Human Services

​​​8. An individual representing Clatsop, Columbia, Coos, Curry, Jackson, Josephine, Lane, or Yamhill County
Laurie Trieger
Lane County Commissioner

​9. An individual representing the City of Portland
Skyler Brocker-Knapp, BA, MA, JD
Senior Policy Advisor to Portland Mayor​

​10. An individual representing a city with a population above 10,000 residents as of July 21, 2021
Joann Linville, RN, EdD
Former Wilsonville City Councilor​


11. An individual representing a city with a population at or below 10,000 residents as of July 21, 2021
Julia Hajduk 
City Manager,
City of Stayton


​12. A representative of the Oregon Coalition of Local Health Officials
Carrie Brogoitti, MPH
Director of Public Health,
Union County Center for Human Development​

​13. A representative of a community mental health program
Rick Treleaven, LCSW
Chief Executive Officer,
BestCare Treatment Services, Inc.

​14. An individual who has experienced a substance use disorder or a representative of an organization that advocates on behalf of individuals with substance use disorders
Fernando Peña, CADCII

​​​15. An individual representing law enforcement, first responders, or jail commanders or wardens
Sheriff Matthew D. Phillips
Clatsop County Sheriff

​16. A member of the House of Representatives appointed by the Speaker of the House of Representatives (nonvoting)
Hai Pham, DMD
Oregon St​​​​ate Representative

​17. A member of the Senate appointed by the President of the Senate (nonvoting)
Lew Frederick
Oregon State Senator


​​​​18. The State Court Administrator (nonvoting)​
The Honorable Celia A. Howes
Multnomah County Circuit Court Judge

Under Oregon’s House Bill 4098 (2022), the Board’s work is guided by the Alcohol and Drug Policy Commission's 2026-2030 Comprehensive Plan. Funding decisions prioritize evidence-based and evidence-informed strategies, equity, and public input.

Oregon Health Authority does not make decisions about how opioid settlement funds are allocated. OHA’s role is to support the OSPTR Board’s work by administering the funds, staffing and coordinating meetings, and managing Board-funded programs.